2nd Quarter - Report
COMPASS CONSULTING GROUP, LLC for AMYLIN PHARMACEUTICALS, INC.
Client
Income
$20,000
Expenses
—
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
General FDA, pharmaceutical, and Medicare issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TED HOLLINGSWORTH | — |
| THOMAS F NEEDLES | — |
| PATRICK A SMITH | — |
Pharmacy PHA
General FDA, pharmaceutical, and Medicare issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TED HOLLINGSWORTH | — |
| THOMAS F NEEDLES | — |
| PATRICK A SMITH | — |
Medical/Disease Research/Clinical Labs MED
General FDA, pharmaceutical, and Medicare issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TED HOLLINGSWORTH | — |
| THOMAS F NEEDLES | — |
| PATRICK A SMITH | — |
Health Issues HCR
General FDA, pharmaceutical, and Medicare issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TED HOLLINGSWORTH | — |
| THOMAS F NEEDLES | — |
| PATRICK A SMITH | — |
Medicare/Medicaid MMM
General FDA, pharmaceutical, and Medicare issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TED HOLLINGSWORTH | — |
| THOMAS F NEEDLES | — |
| PATRICK A SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.